Evidence map›Paper›PMID 37948513›Full record

ArticleScience advances2023

Optimal control pulses for the 1.2-GHz (28.2-T) NMR spectrometers.

David Joseph, Christian Griesinger

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Optimal control of spin systems.Science advances · 2026
    Review
  2. Article
  3. Nuclear-Spin Hyperpolarization of Biomolecules by Optically Enhanced NMR at Ultra-High Field.Journal of the Chinese Chemical Society. Zhongguo hua xue hui (Taipei, Taiwan) · 2026
    Article
  4. LowCOST-HSQC Variants for Fast-Pulsing High ωMagnetic resonance in chemistry : MRC · 2026
    Article
  5. Article
  6. Ultrabroadband 1D and 2D NMR Spectroscopy.Angewandte Chemie (International ed. in English) · 2026
    Article
  7. Review
  8. Article
  9. OptimizedInternational journal of molecular sciences · 2025
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

David JosephMax Planck Institute for Multidisciplinary Sciences, Göttingen, Niedersachsen D-37077, Germany.ORCID 0000-0003-4015-9430
Christian GriesingerMax Planck Institute for Multidisciplinary Sciences, Göttingen, Niedersachsen D-37077, Germany.ORCID 0000-0002-1266-4344
Max Planck Institute for the Study of Religious and Ethnic Diversity · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability to measure nuclear magnetic resonance (NMR) spectra with a large sample volume is crucial for concentration-limited biological samples to attain adequate signal-to-noise (S/N) ratio. The possibility to measure with a 5-mm cryoprobe is currently absent at the 1.2-GHz NMR instruments due to the exceedingly high radio frequency power demands, which is four times compared to 600-MHz instruments. Here, we overcome the high-power demands by designing optimal control (OC) pulses with up to 20 times lower power requirements than currently necessary at a 1.2-GHz spectrometer. We show that multidimensional biomolecular NMR experiments constructed using these OC pulses can bestow improvement in the S/N ratio of up to 26%. With the expected power limitations of a 5-mm cryoprobe, we observe an enhancement in the S/N ratio of more than 240% using our OC sequences. This motivates the development of a cryoprobe with a larger volume than the current 3-mm cryoprobes.

Identifiers

PMID37948513
PMCPMC10637738
OpenAlexW4388562258

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.